P. CASTROGIOVANNI, A. GORACCI, P. BISCONTI, A. CASTROGIOVANNI, L. CIONINI - Vol. 9, December 2003, Issue 4
Testo Bibliografia Summary Indice
Psicofarmaci e personalità: modificazioni
degli schemi cognitivi in corso di trattamenti farmacologici
Psychopharmacological treatment and personality: cognitive schemes changes
during pharmacological treatments
1 Neisser U. Cognition and reality: principles and implications of cognitive psychology. San Francisco: Freeman 1976.
2 Bartlett FC. Remembering. Cambridge, Cambridge University Press. Trad. It.: La Memoria. Milano: Franco Angeli 1974.
3 Bowlby J. Attachment and loss. Attachment. New York: Basic Books 1965;I.
4 Bowlby J. Attachment and loss. Separation. New York: Basic Books 1973;II.
5 Bowlby J. Attachment and loss. Loss. New York: Basic Books 1980;III.
6 Guidano VF, Liotti G. Cognitive processes and emotional disorders. New York: Guildfor 1983.
7 Guidano VF. The complexity of the self: a developmental approach to psychopatology and therapy. New York: Guildfor 1987.
8 Cionini L. Psicoterapia cognitiva: teoria e metodo dell’intervento terapeutico. Roma: La Nuova Italia Scientifica 1991.
9 Cionini L. L’assessment. In: Bara BG, ed. Manuale di psicoterapia cognitiva. Torino: Bollati Boringhieri 1997:345-405.
10 Crittenden PM. Attachment and psychopatology. In: Goldberg R, Murir R, Kerr J, eds. Attachment theory: social, developmental, and clinical perspectives. Hillsdale: The analytic press 1995.
11 Cionini L. La psicoterapia cognitivo-costruttivista. In: Cionini L, ed. Psicoterapie: modelli a confronto. Roma: Carrocci 1998.
12 Reda MA. Sistemi cognitivi complessi e psicoterapia. Roma: La Nuova Italia Scientifica 1986.
13 Bara BG. Manuale di psicoterapia cognitiva. Torino: Bollati Boringhieri 1996.
14 Cionini L, Provvedi G. Questionario sugli schemi prevalenti (in stampa).
15 Piaget J. La lecture de l’experience. Paris: PUF 1958.
16 Bowlby J. A secure base. London: Routledge 1988.
17 Trevarthen C. An infant motives for speaking and thinking in the culture. In: Wold AM, ed. The dialogical alternative. Oslo: Scandinavian University Press 1992.
18 Plomin R, De Fries JC, Mc Clearn GE, Rutter M. Behavioral genetics. New York: Feeman 1997.
19 Silk KR. Biology of personality disorders. Washington DC: American Psychiatric Press 1998.
20 Bond JA. Neurotrasmitters, temperament and social functioning. Eur Neuropsychopharmacol 2001;11:261-74.
21 Alloy LB, Abramson LY, Whitehouse WG, Hogan ME, Tashman NA, Steinberg DL, et al. Depressogenic cognitive styles: predictive validity, information processing and personality characteristics, and developmental origins. Behav Res Ther 1999;37:503-31.
22 Jarrett RB, Kraft D, Doyle J, Foster BM, Eaves GG, Silver PC. Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial. Arch Gen Psychiatry 2001;58:381-8.
23 Blackburn IM, Moore RG. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. Br J Psychiatry 1997;171:328-34.
24 Haykal RF, Akiskal HS. The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management. J Clin Psychiatry 1999;60:508-18.
25 Hellerstein DJ, Kocsis JH, Chapman D, Stewart JW, Harrison W. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality. Am J Psychiatry 2000;157:1436-44.
26 Mitchell PJ, Fletcher A, Redfern PH. Is antidepressant efficacy revealed by drug-induced changes in rat behaviour exhibited during social interaction? Neurosci Biobehav Rev 1991;15:539-44.
27 Mitchell PJ, Redfern PH. Chronic treatment with clomipramine and mianserin increases the hierarchical position of subdominant rats haused in triads. Behav Pharmacol 1992;3:239-47.
28 Niesink RJ, Van Ree JM. Antidepressant drugs normalize the increased social behaviour of pairs of male rats induced by short term isolation. Neuropharmacology 1982;21:1343-8.
29 Allgulander C, Cloninger CR, Przybeck TR, Brandt L. Changes on the Temperament and Character Inventory after paroxetine treatment in volunteers with Generalized Anxiety Disorder. Psychopharmacol Bull 1998;34:165-6.
30 Cloninger CR, Prybeck TR, Svrakic DM, Wetzel RD. Temperament and Character Inventory. In: Conti L, ed. Repertorio delle scale di valutazione. Firenze: SEE 2000.
31 Black KJ, Sheline YI. Personality disorder scores improve with effective pharmacotherapy of depression. J Affect Disord 1997;43:11-8.
32 Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993;50:975-90.
33 Brody AL, Saxena S, Fairbanks LA, Alborzian S, Demaree HA, Maidment KM, et al. Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine. J Clin Psychiatry 2000;61:349-55.
34 Ampollini P, Marchesi C, Signifredi R, Maggini C. Temperament and personality features in panic disorder with or without comorbid mood disorders. Acta Psychiatr Scand 1997;95:420-3.
35 Ekselius L, Von Knorring L. Changes in personality traits during treatment with sertraline or citalopram. Br J Psychiatry 1999;174:444-8.
36 Chien AJ, Dunner DL. The Tridimensional Personality Questionnaire in depression: state versus trait issues. J Psychiatr Res 1996;30:21-7.
37 Bagby RM, Levitan RD, Kennedy SH, Levitt AJ, Joffe RT. Selective alteration of personality in response to noradrenergic and serotonergic antidepressant medication in depressed sample: evidence of non-specificity. Psychiatry Res 1999;86:211-6.
38 Dubini A, Bose M, Polin V. Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning. J Psychopharmacol 1997;11(Suppl 4):S17-23.
39 Massana J. Reboxetine versus fluoxetine: an overview of efficacy and tolerability. J Clin Psychiatry 1998;59(Supp 14l):S8-10.
40 Kasper S. From symptoms to social functioning: differential effects of antidepressant therapy. Int Clin Psychopharmacol 1999;14(Suppl 1):S27-31.
41 Akkerman K, Carr V, Lewin T. Changes in ego defenses with recovery from depression. J Nerv Ment Dis 1992;180:634-8.
42 Andrews W, Parker G, Barrett E. The SSRI antidepressants: exploring their "other" possible properties. J Affect Disord 1998;49:141-4.
43 Gelfin Y, Gorfine M, Lerer B. Effect of clinical doses of fluoxetine on psychological variables in healthy volunteers. Am J Psychiatry 1998;155:290-2.
44 Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RC, et al. Selective alteration of personality and social behaviour by serotonergic intervention. Am J Psychiatry 1998;155:373-9.
45 Tse WS, Bond AJ. Serotonergic involvement in the psychosocial dimension of personality. J Psychopharmacol 2001;15:195-8.
46 Kramer PD. La pillola della felicità. Milano: Sansoni Editore 1994.